Thermo-chemotherapy Induced miR-218 upregulation inhibits the invasion of gastric cancer via targeting Gli2 and E-cadherin

Thermo-chemotherapy has been proven to reduce the invasion capability of cancer cells. However, the molecular mechanism underlying this anti-invasion effect is still unclear. In this study, the role of thermo-chemotherapy in the inhibition of tumor invasion was studied. The results demonstrated that...

Full description

Saved in:
Bibliographic Details
Published inTumor biology Vol. 36; no. 8; pp. 5807 - 5814
Main Authors Ruan, Qiang, Fang, Zhi-yuan, Cui, Shu-zhong, Zhang, Xiang-liang, Wu, Yin-bing, Tang, Hong-sheng, Tu, Yi-nuo, Ding, Yan
Format Journal Article
LanguageEnglish
Published Dordrecht Springer Netherlands 01.08.2015
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Thermo-chemotherapy has been proven to reduce the invasion capability of cancer cells. However, the molecular mechanism underlying this anti-invasion effect is still unclear. In this study, the role of thermo-chemotherapy in the inhibition of tumor invasion was studied. The results demonstrated that expression of miR-218 was downregulated in gastric cancer tissues, which had a positive correlation with tumor invasion and metastasis. In vitro thermo-chemotherapy increased miR-218 expression in SGC7901 cells and inhibited both proliferation and invasion of cancer cells. Gli2 was identified as a downstream target of miR-218, and its expression was negatively regulated by miR-218. The thermo-chemotherapy induced miR-218 upregulation was also accompanied by increasing of E-cadherin expression. In conclusion, the present study indicates that thermo-chemotherapy can effectively decrease the invasion capability of cancer cells and increase cell-cell adhesion. miR-218 and its downstream target Gli2, as well as E-cadherin, participate in the anti-invasion process.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1010-4283
1423-0380
DOI:10.1007/s13277-015-3250-4